KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Hematology / 2021 / Cilt: 38 - Sayı: 1

Kronik Lenfositik Lösemide İbrutinib Kaynaklı Kardiyak Tamponad

Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia

Keisuke KİDOGUCHİ
Yasushi KUBOTA
Yuki NİSHİMURA
Haruna KİZUKA SANO
Shinya KİMURA
Sayfa
83–85
Yayın Tarihi
2022-11-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

KİDOGUCHİ, K., KUBOTA, Y., NİSHİMURA, Y., SANO, H. K., KİMURA, S. (2022). Kronik Lenfositik Lösemide İbrutinib Kaynaklı Kardiyak Tamponad. Turkish Journal of Hematology, Cilt: 38 - Sayı: 1, 83–85. https://ajindex.com/articles/606541

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

  1. Spodick DH. Acute cardiac tamponade. N Engl J Med 2003;349:684-690
  2. Atar S, Chiu J, Forrester JS, Siegel RJ. Bloody pericardial effusion in patients with cardiac tamponade. Chest 1999;116:1564-1569
  3. Maisch B, Ristic A, Pankuweit S. Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis 2010;53:157-163
  4. Paydas S. Management of adverse effects/toxicity of ibrutinib. Crit Rev Oncol Hematol 2019;136:56-63
  5. Miatech J, Hughes JH, McCarty DK, Stagg MP. Ibrutinib-associated cardiac tamponade with concurrent antiplatelet therapy. Case Rep Hematol 2020;2020:4282486
  6. Shatzel JJ, Olson SR, Tao DL, McCarty OJ, Danilov AV, DeLoughery TG. Ibrutinib-associated bleeding; pathogenesis, management, and risk reduction strategies. J Thromb Haemost 2017;15:835-847
  7. Kamel S, Horton L, Ysebaert L, Levade M, Burbury K, Tan S, Cole-Sinclair M, Reynolds J, Filshie R, Schischka S, Khot A, Sandhu S, Keating MJ, Nandurkar H, Tam CS. Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation. Leukemia 2015;29:783-787.